OR5AS1 inhibitors are a class of chemical compounds that interact with and inhibit the activity of the OR5AS1 protein, which is a member of the olfactory receptor family. Olfactory receptors, such as OR5AS1, belong to a large family of G protein-coupled receptors (GPCRs) that are primarily responsible for the detection of odorants and the initiation of olfactory signal transduction. These receptors are highly expressed in the olfactory epithelium, where they play a critical role in sensing environmental stimuli, although some members of the olfactory receptor family are also expressed in non-olfactory tissues. OR5AS1 specifically is one such receptor that has been shown to bind with specific ligands to trigger downstream signaling pathways associated with sensory perception. By inhibiting the activity of OR5AS1, these compounds block or modulate the receptor's ability to bind its ligands and alter the signal transduction pathways it controls.
The inhibition of OR5AS1 by these compounds involves various molecular mechanisms. Some inhibitors may act as antagonists, competitively binding to the active site of OR5AS1, preventing the receptor from engaging with its natural ligands. Others may interfere with receptor dimerization, or alter the receptor's conformational dynamics, rendering it inactive. The structural design of these inhibitors often relies on detailed molecular models of OR5AS1's binding pocket and its associated transmembrane regions. Since OR5AS1, like other GPCRs, exhibits conformational flexibility, identifying inhibitors that can stably interact with its active or inactive states requires sophisticated computational and experimental methods, such as molecular docking, in silico modeling, and ligand-binding assays. This class of inhibitors is studied for its ability to provide insight into the functional modulation of GPCR-related signal pathways, particularly within olfactory signaling cascades.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may repress OR5AS1 by promoting chromatin compaction, thus hindering access to transcriptional machinery required for OR5AS1 gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical could reduce OR5AS1 expression by preventing the addition of methyl groups to the gene's promoter, a modification that typically suppresses gene activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
By selectively blocking the methylation of cytosine-phosphate-guanine (CpG) sites on the OR5AS1 gene promoter, RG108 may lead to a decrease in OR5AS1 expression levels. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may decrease OR5AS1 expression by causing the accumulation of acetylated histones, which are associated with condensed, transcriptionally inactive chromatin regions. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A can bind to the OR5AS1 promoter and preclude the binding of essential transcription factors, thereby reducing the initiation of OR5AS1 transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This chemical could inhibit the transcription of OR5AS1 by intercalating into its DNA and preventing the advancement of RNA polymerase along the gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate may downregulate OR5AS1 by increasing histone acetylation, leading to a repressive chromatin environment that is not conducive to gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By inhibiting DNA methyltransferases, 5-Aza-2′-Deoxycytidine may lead to the hypomethylation of the OR5AS1 promoter, resulting in a reduction in gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid could decrease OR5AS1 expression by binding to retinoic acid response elements in the gene's promoter, altering the recruitment of DNA-binding proteins necessary for gene activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG may downregulate OR5AS1 by hindering the activity of transcription factors specifically required for the expression of this olfactory receptor gene. | ||||||